Providence Therapeutics

1 follower


Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.

Headquarters

Toronto, Canada

Employees

51-200

Links

Org chart

Bradley Sorenson
President & CEO

Bradley Sorenson

Collapse
Aleksandra Pastrak MD, PhD
Chief Medical Officer
Daran Simpson, Prosci
Vice President Shared Services
Eric Marcusson
Co-Founder, Board Member & Chair of the SAB
Jennifer Bryan
Vice President of Intellectual Property
Leighette S.
Senior Director, People & Culture
Mark Gilmour
Vice President Regulatory Affairs
Mélanie Bérubé
Senior Director Preclinical/Nonclinical Studies
Murali S.
Director - Analytical Development
Natalia Martin Orozco
Chief Science Officer
Rajesh Krishnan, Ph. D.
Senior Director Formulation
Sarah Serl
Director, Program and Alliance Management
Élisa Jean
Supervisor Quality Control & Stability
Richard Tran
Clinical Project Manager
Shahabedin Eslami, MASc, PMP
Technical Operations Specialist and Project Manager
Brandi Lalonde
Operations Coordinator
Jordan Schwartz, PhD
Director Of Partnerships And Innovation
Linda Tamez
Project Manager